Brief: Liminal Biosciences Announces Priorities For 2023

Liminal BioSciences

06/01/2023 21:08

Jan 6 (Reuters) - Liminal BioSciences Inc  LMNL.O :
    * LIMINAL BIOSCIENCES ANNOUNCES PRIORITIES FOR 2023
    * LIMINAL BIOSCIENCES INC - PLANS TO DIVEST ITS REMAINING
NON-CORE
ASSETS, TO FURTHER EXTEND RUNWAY
    * LIMINAL BIOSCIENCES INC - SELECTION OF INITIAL TARGET
INDICATION
FOR LMNL6511 EXPECTED IN COMING MONTHS
    * LIMINAL BIOSCIENCES INC - OXER1 ANTAGONIST DEVELOPMENT
PROGRAM
PROGRESSING TO IDENTIFICATION OF LEAD PRECLINICAL DRUG CANDIDATE
IN H1 2023
    * LIMINAL BIOSCIENCES INC - CLOSED DECEMBER 2022 WITH JUST
OVER
CAD 37 MILLION CASH ON HAND, EXPECTING TO PROVIDE A RUNWAY INTO
EARLY 2024

Source text for Eikon:  ID:nPn9lMwGja 
Further company coverage:  LMNL.O 
 ((Reuters.Briefs@thomsonreuters.com;;))